# Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients

> **NCT04793984** · NA · COMPLETED · sponsor: **Marinomed Biotech AG** · enrollment: 14 (actual)

## Conditions studied

- Covid19

## Interventions

- **DEVICE:** Carragelose
- **DEVICE:** NaCl

## Key facts

- **NCT ID:** NCT04793984
- **Lead sponsor:** Marinomed Biotech AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-08
- **Primary completion:** 2022-07-30
- **Final completion:** 2022-07-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04793984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04793984, "Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04793984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*